A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 107 participants.
Also called NCT05126238
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 107 participants
- Sponsor
- Negovsky Reanimatology Research Institute
- Registry
-
NCT05126238
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Russia
- Registry status
- Terminated
Technical summary
Registry record NCT05126238. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-20 (actual); primary completion 2025-05-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
- Condition
- Carotid Artery Diseases
- Condition
- Carotid Artery Stenosis
- Intervention (Drug)
- Lithium Carbonate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Negovsky Reanimatology Research Institute
- Collaborator
- Demikhov Municipal Clinical Hospital 68
Record details
- Record id
cardio:ct-nct05126238- Content hash
a01b83f7baccee515baaa85f614630282f5e59608509ea04ee3c6cf891a8ec1c